Lv0
0 积分 2024-12-29 加入
Monitoring minimal residual disease in acute leukemia: Technical challenges and interpretive complexities
2天前
已完结
Assessment of Minimal Residual Disease in Standard-Risk AML
2天前
已完结
Association of Measurable Residual Disease With Survival Outcomes in Patients With Acute Myeloid Leukemia
2天前
已完结
Characterization of children with FLT3-ITD acute myeloid leukemia: a report from the AIEOP AML-2002 study group
2天前
已完结
Approaching a therapeutic inflection point for FLT3-mutated AML
2天前
已完结
Approaching a therapeutic inflection point for FLT3-mutated AML
2天前
已关闭
Approaching a therapeutic inflection point for FLT3-mutated AML
2天前
已关闭
皖公网安备34019202002308
